Gilead was focused on profits, not patients: Report

mardi 1 décembre 2015

An investigation by senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the drug. Gilead was focused on profits, not patients: Report

0 commentaires:

Enregistrer un commentaire